.The Miracle in the “Stable”: Why Ashton’s Latest MRI is the Best Birthday Gift Ever
In the world of pediatric oncology, there are words that carry more weight than any trophy or title. For five-year-old Ashton, those words arrived just in time for a very special celebration: “Stable” and “Negative.”
Ashton is currently seven months into a battle against a rare and aggressive foe: CNS neuroblastoma with FOXR2 activation. It is a diagnosis that sounds like a foreign language to most, but for Ashton’s family, it has been the landscape of their lives since last summer.
But last week, the landscape shifted toward the light.
The Double Answer to Prayer
The results of Ashton’s latest round of scans and tests brought the kind of relief that leaves you breathless:
-
The MRI: Returned stable, showing no signs of recurrence. In the fight against brain cancer, “stable” is a victory—it means the line is being held.
-
The Lumbar Puncture: Confirmed negative for malignancy, meaning the cancer has not spread into his spinal fluid.
For a family that has spent more than 200 days navigating the specialized corridors of oncology wards, this news was a “double answer” to months of collective prayer.
Basketball, Birthdays, and Back Home
The timing of the news felt like a wink from above. It arrived just as the family was preparing to celebrate Ashton’s dad’s birthday. To mark the milestone, they headed to an OSU men’s basketball game, trading hospital gowns for jerseys and monitor beeps for the roar of the crowd.
After completing his most recent round of chemotherapy, Ashton is now back where he belongs: home. While the chemotherapy takes a toll on a five-year-old’s body, it hasn’t touched his spirit. He remains the same gentle, kind, and heart-filled boy who started this journey seven months ago.
Understanding the Fight: CNS Neuroblastoma-FOXR2
To understand why this stable MRI is such a big deal, you have to understand the rarity of Ashton’s condition. CNS neuroblastoma with FOXR2 activation is a newly classified, high-grade embryonal tumor.
-
The Challenge: It is considered highly malignant and traditionally difficult to treat.
-
The Hope: Recent 2025 and 2026 data from institutions like St. Jude suggest that while these tumors are aggressive, patients who respond well to multimodal therapy (chemotherapy, radiation, and surgery) have significantly improved long-term outcomes.
Ashton isn’t just a patient; he is a pioneer in a new era of targeted pediatric care.
The Road Ahead
Ashton’s fight isn’t over. There are more tests, more treatments, and more “wait-and-see” moments on the calendar. But his courage remains the anchor for everyone around him. His family continues to walk the tightrope of schedules and worry, but they do it with a renewed sense of strength.
The Prayer Request Today:
-
For Continued Stability: Pray that his scans remain clear and his body continues to reject the malignancy.
-
For Strength: Pray for Ashton’s little body to recover quickly from the chemo and for his parents to have a “peace that passes understanding” during the waiting.
-
For the Researchers: Pray for the scientists studying the FOXR2 pathway, that Ashton’s journey helps unlock cures for children who come after him.
Keep smiling, Ashton. You’ve got the heart of a Buckeye and the soul of a warrior. We are all on your team. 🤍🏀
You may also like
Leave a Reply